ArticlePLoS pathogens2025
High prevalence of simian foamy virus infection of South American Indians.
Article in PLoS pathogens, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- Updated practice for detection of viral infections in breeding macaques.Zoological research · 2025Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Simian foamy viruses (SFV) are retroviruses that widely infect nonhuman primates of New and Old-World origin and exhibit long-standing co-evolution with their hosts. Humans can acquire SFV from zoonotic exposures but are not known to be endemically infected and typically exhibit dead-end infections. South American Indian populations (Amerindians) historically have frequent contact with New World monkeys (NWM) and are endemically infected with the retrovirus human T-cell lymphotropic virus type 2 (HTLV-2) originally acquired before populating the Americas. We tested archived serum samples collected from numerous South American Indian persons (n = 1,998) in 1966-1997 from 18 tribes by validated ELISA and Western blot assays containing NWM SFV antigens. We also screened samples for HTLV-2 to compare SFV and HTLV-2 infection. We combined demographic and familial relationship data with the serologic results to evaluate transmission dynamics. We found a high SFV seroprevalence of 9.5% in 15 tribes compared to an HTLV-2 prevalence of 6.1% in 11 tribes. Testing of seropositive samples with Old World SFV antigen showed no reactivity confirming a NWM SFV origin. We found the odds of SFV and HTLV positivity increased with age and documented familial clustering of SFV among spouses and children. Serotyping showed co-circulation of SFV from different NWM species. Our results show that NWM SFV established longstanding prevalence among Amerindians post population of America. The high SFV prevalence will enable studies of disease association and human transmissibility to better understand the public health significance of SFV infections in humans.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.